Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hope for hard-to-treat blood cancers? early trial begins.

NCT ID NCT06590961

First seen Nov 19, 2025 · Last updated May 22, 2026 · Updated 27 times

Summary

This early-phase study tests a new drug, UBX-303061, in people with certain blood cancers (like lymphoma or leukemia) that have returned or not responded to prior treatments. The main goals are to check safety and find the right dose. About 94 adults will take part in this first human study.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RELAPSED/REFRACTORY B-CELL MALIGNANCIES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • AidPort

    NOT_YET_RECRUITING

    Grodzisk Wielkopolski, Wielkopolskie Voivodeship, 62-065, Poland

  • Asan Medical Center

    RECRUITING

    Seoul, Seoul, 05505, South Korea

  • Gabrail Cancer Center

    RECRUITING

    Canton, Oklahoma, 44718, United States

  • MD Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

  • MICS Centrum Medyczne Toruń

    NOT_YET_RECRUITING

    Torun, Kuyavian-Pomeranian Voivodeship, 87-100, Poland

  • Pratia, MTZ Clinical Research

    NOT_YET_RECRUITING

    Warsaw, Mazowieckie Voivodeship, 02-172, Poland

  • Pratia, Oncology Katowice

    NOT_YET_RECRUITING

    Katowice, Silesian Voivodeship, 40-519, Poland

  • Samsung Medical Center

    RECRUITING

    Seoul, Seoul, 06351, South Korea

  • The Catholic University of Korea, Seoul St. Mary's Hospital

    RECRUITING

    Seoul, Seoul, 06591, South Korea

  • The Catholic University of Korea, Yeouido St. Mary's Hospital

    RECRUITING

    Seoul, Seoul, 07345, South Korea

  • University of Michigan

    RECRUITING

    Ann Arbor, Michigan, 48109, United States

Conditions

Explore the condition pages connected to this study.